T cell receptor activation via major histocompatibility complex class I and class II pathways

T cell activation via major histocompatibility complex class I and II pathways refers to the fundamental immunological process by which T lymphocytes recognize antigens presented by antigen-presenting cells. This occurs through two main routes: * MHC Class I Pathway: All nucleated cells present endogenous peptides on their surface using MHC class I molecules. These complexes are recognized by cytotoxic CD8+ T cells. This interaction is crucial for detecting virus-infected or malignant cells[1][5][7]. * MHC Class II Pathway: Professional antigen-presenting cells—such as dendritic cells, macrophages, and B lymphocytes—present exogenous peptides using MHC class II molecules. These are recognized by helper CD4+ T cells that coordinate broader immune responses including antibody production and recruitment of other immune effectors[5][7]. The recognition event triggers intracellular signaling cascades through the T cell receptor complex involving kinases like Lck and ZAP70, leading to transcriptional changes that drive proliferation, differentiation into effector subsets, cytokine secretion, or tolerance/anergy depending on context[2][4][6]. Co-stimulatory signals from receptors like CD28 are required for full activation. This entry does not refer to a single molecular entity but rather describes an essential immunological mechanism involving multiple proteins and cellular interactions. Therefore it is not considered a canonical therapeutic target itself but encompasses many validated drug targets within its component parts. "The T-cell antigen receptor (TCR) complex participates in T-cell activation upon presentation of an antigen peptide bound to either MHC Class I or Class II residing on antigen-presenting cells... Protein tyrosine phosphorylation mediated by Src family kinases Lck/Fyn initiates downstream events leading ultimately to effector functions"[4]. "Both classes [MHC-I/II] share the task of presenting peptides on the cell surface for recognition by T-cells... Immunogenic peptide–MHC class I complexes are presented on nucleated cells [to] cytotoxic CD8+ T-cells... pMHCII [activates] CD4+ helper T-cells"[7]. Because this term describes an entire biological process rather than a discrete molecule/receptor/protein family typically targeted pharmacologically—and because it lacks specificity—it should be flagged as incorrect if used where only molecular targets should be listed.

Other names

T cell activation via MHC-I and MHC-IITCR signaling via MHC class I and IIAntigen presentation to T cells by MHC molecules